Please login to the form below

Not currently logged in
Email:
Password:

Celgene appoints UK inflammation and immunology director

Rob Moore joins from Abbott
celgene Rob-Moore

Celgene has appointed Rob Moore to head its inflammation and immunology business in the UK and Ireland.

Moore joins from AbbVie (formerly Abbott) where he was rhemautology senior business unit manager for the UK.

During his time at Abbott/AbbVie Moore worked across Western Europe and Canada, including two years in Paris as immunology commercial director, dermatology.

He also set up and led the UK sales team in gastroenterology before moving on to create the business unit for dermatology in 2009, wherein he led the launch of the huge-selling anti-inflammatory drug Humira (adalimumab).

Sam Pearce, VP and general manager, Celgene UK and Ireland, said: “We have an opportunity here to offer effective solutions to patients in need, and are confident that Rob has the knowledge and experience to help us deliver these. “

14th March 2014

From: Sales

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
BOLDSCIENCE

We know what it takes to create brands, to start new conversations, to simply communicate complex science, to change lives…...

Latest intelligence

How a design mindset can lead to better medical outcomes
By adopting a design philosophy, healthcare companies can develop communications that allow healthcare professionals (HCPs) to better meet the needs of their patients. Imaginatively designed content combined with patient insights...
How does the government plan to reshape the NHS?
Oli Hudson, of Wilmington Healthcare, explores the government’s new white paper, which proposes key reforms for health and social care...
Want to give perfect client service? Tough luck, you’re human
In this article an ex-client of mine, Liz Skrbkova, and I explore the (unhelpful) pressures of trying to perfect the client-agency relationship...

Infographics